Lifestyle or pharmacotherapy in cardio-metabolic disease prevention
Изменение образа жизни или фармакотерапия в профилактике кардиометаболических заболеваний
2023-01-01
SCID: 54.1/3tukvqat
Discuss with AI
cardio-metabolic multimorbiditylifestyle modificationphysical activitypolypharmacysmoking cessation
Figures from the paper
Abstract (AI)
Cardio-metabolic diseases are the leading causes of premature death worldwide. The conditions are together some of the most prevalent and severe multimorbidities and include conditions such as diabetes, hypertension, coronary heart disease and stroke. People with these conditions are at a higher risk of all-cause death and have a reduction in life expectancy when compared to patients without cardio-metabolic disorders. As a result of the increasing prevalence and impact of cardio-metabolic multimorbidity on disability, no healthcare system can 'treat' its way out of this pandemic. 'Treating our way out' requires the use of multiple medications which can lead to improper prescribing, insufficient compliance, overdosing or underdosing, improper drug choice, insufficient monitoring, unfavourable drug effects, and drug interactions and inappropriate wastes and costs. Therefore, individuals living with these conditions should be empowered to adopt lifestyle changes that foster independent living with their conditions. Adopting these healthy lifestyles such as smoking cessation, improving dietary habits, sleep hygiene and physical activity is a suitable adjunctive measure if not an alternative to polypharmacy in cardio-metabolic multimorbidity.
Key Findings
1
Cardio-metabolic diseases, including diabetes, hypertension, coronary heart disease, and stroke, are major causes of premature death and reduced life expectancy.
2
Cardio-metabolic multimorbidity is too prevalent and burdensome for healthcare systems to manage through pharmacotherapy alone.
3
Healthy lifestyle changes are recommended as an adjunct or potential alternative to polypharmacy in cardio-metabolic multimorbidity.
4
Lifestyle interventions such as smoking cessation, healthier eating, improved sleep hygiene, and physical activity should be promoted for independent disease management.
5
Polypharmacy can cause inappropriate prescribing, poor adherence, dosing errors, adverse effects, drug interactions, inadequate monitoring, and unnecessary costs.
Research Object
cardio-metabolic multimorbidity, including diabetes, hypertension, coronary heart disease, and stroke
Research Subject
the role and comparative use of lifestyle changes versus pharmacotherapy, including polypharmacy, in preventing and managing cardio-metabolic disease
Publication Details
Publication Date
2023-01-01
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest